{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:46:22Z","timestamp":1792010782225,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["2-2007-105"],"award-info":[{"award-number":["2-2007-105"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA021765"],"award-info":[{"award-number":["P30 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.celrep.2023.112106","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:11:00Z","timestamp":1676301060000},"page":"112106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T\u00a0cell development"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-5317","authenticated-orcid":false,"given":"Alexandra H.","family":"Mandarano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarsha L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine M.","family":"Creasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-221X","authenticated-orcid":false,"given":"Marie","family":"Wehenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1912-3302","authenticated-orcid":false,"given":"Marygrace","family":"Duggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-9189","authenticated-orcid":false,"given":"Benjamin A.","family":"Wilander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Chase","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"High","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-0372","authenticated-orcid":false,"given":"Maureen A.","family":"McGargill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112106_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112106_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12916-017-0958-6","article-title":"Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study","volume":"15","author":"Rogers","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.celrep.2023.112106_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New frontiers in the treatment of type 1 diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2023.112106_bib4","series-title":"Autoimmune Diseases","year":"2019"},{"key":"10.1016\/j.celrep.2023.112106_bib5","series-title":"Estimates of Diabetes and its Burden in the United States","first-page":"32","year":"2020"},{"key":"10.1016\/j.celrep.2023.112106_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/dc17-2131","article-title":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study","volume":"41","author":"Carey","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celrep.2023.112106_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwv292","article-title":"Prediction and prevention of autoimmune disease in the 21st century: a review and preview","volume":"183","author":"Rose","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.celrep.2023.112106_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fendo.2017.00343","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2023.112106_bib9","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.3390\/ijms22084239","article-title":"Harnessing the endogenous plasticity of pancreatic islets: a feasible regenerative medicine therapy for diabetes?","volume":"22","author":"Lorenzo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2023.112106_bib10","doi-asserted-by":"crossref","first-page":"29066","DOI":"10.1074\/jbc.273.44.29066","article-title":"DRAKs, novel serine\/threonine kinases related to death-associated protein kinase that trigger apoptosis","volume":"273","author":"Sanjo","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.112106_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.immuni.2004.10.008","article-title":"A deficiency in Drak2 results in a T\u00a0cell hypersensitivity and an unexpected resistance to autoimmunity","volume":"21","author":"McGargill","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112106_bib12","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.4049\/jimmunol.181.11.7593","article-title":"Drak2 regulates the survival of activated T\u00a0cells and is required for organ-specific autoimmune disease","volume":"181","author":"McGargill","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/intimm\/dxu146","article-title":"Drak2 is not required for tumor surveillance and suppression","volume":"27","author":"Edwards","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib14","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4049\/jimmunol.181.3.2084","article-title":"Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis","volume":"181","author":"Wang","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/08916930600996700","article-title":"Anti-viral effector T\u00a0cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system","volume":"40","author":"Ramos","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.celrep.2023.112106_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jb\/mvm236","article-title":"Nuclear localization signal and phosphorylation of Serine350 specify intracellular localization of DRAK2","volume":"143","author":"Kuwahara","year":"2008","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.celrep.2023.112106_bib17","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.0802255","article-title":"Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation","volume":"182","author":"Mao","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib18","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cmet.2021.09.008","article-title":"DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2023.112106_bib19","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1038\/onc.2014.423","article-title":"Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-\u03b21 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4","volume":"34","author":"Park","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2023.112106_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.celrep.2012.09.028","article-title":"DRAK2 participates in a negative feedback loop to control TGF-\u03b2\/Smads signaling by binding to type I TGF-\u03b2 receptor","volume":"2","author":"Yang","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112106_bib21","doi-asserted-by":"crossref","first-page":"e0123650","DOI":"10.1371\/journal.pone.0123650","article-title":"Drak2 does Not regulate TGF-\u03b2 signaling in T\u00a0cells","volume":"10","author":"Harris","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112106_bib22","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.4049\/jimmunol.181.11.7606","article-title":"Enhanced T\u00a0cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity","volume":"181","author":"Ramos","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib23","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1074\/jbc.M606675200","article-title":"Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes","volume":"282","author":"Friedrich","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.112106_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/intimm\/dxh315","article-title":"DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection","volume":"17","author":"Friedrich","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fimmu.2013.00324","article-title":"Modulation of T\u00a0cell metabolism and function through calcium signaling","volume":"4","author":"Fracchia","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jb\/mvg137","article-title":"The apoptosis-inducing protein kinase DRAK2 is inhibited in a calcium-dependent manner by the calcium-binding protein CHP","volume":"134","author":"Kuwahara","year":"2003","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.celrep.2023.112106_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/jcb.21910","article-title":"Drak2 overexpression results in increased beta-cell apoptosis after free fatty acid stimulation","volume":"105","author":"Mao","year":"2008","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.celrep.2023.112106_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41590-018-0289-6","article-title":"Thymic regulatory T\u00a0cells arise via two distinct developmental programs","volume":"20","author":"Owen","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.immuni.2007.11.021","article-title":"A two-step process for thymic regulatory T\u00a0cell development","volume":"28","author":"Lio","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112106_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-018-0083-6","article-title":"Central CD4+ T\u00a0cell tolerance: deletion versus regulatory T\u00a0cell differentiation","volume":"19","author":"Klein","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.1601301","article-title":"Endogenous Nur77 is a specific indicator of antigen receptor signaling in human T and B cells","volume":"198","author":"Ashouri","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20110308","article-title":"T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse","volume":"208","author":"Moran","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112106_bib33","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4049\/jimmunol.1900662","article-title":"Regulatory T\u00a0cell development in the thymus","volume":"203","author":"Owen","year":"2019","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib34","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4049\/jimmunol.2000612","article-title":"Dynamic roles for IL-2\u2013STAT5 signaling in effector and regulatory CD4+ T\u00a0cell populations","volume":"205","author":"Jones","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib35","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20082824","article-title":"In\u00a0vivo expansion of T reg cells with IL-2\u2013mAb complexes: induction of resistance to EAE and long-term acceptance of islet\u00a0allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112106_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nprot.2010.196","article-title":"Absolute quantification of protein and post-translational modification abundance with stable isotope\u2013labeled synthetic peptides","volume":"6","author":"Kettenbach","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2023.112106_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0303-7207(97)00164-0","article-title":"Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5","volume":"133","author":"Pircher","year":"1997","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.celrep.2023.112106_bib39","doi-asserted-by":"crossref","first-page":"eaaw2707","DOI":"10.1126\/sciimmunol.aaw2707","article-title":"Conversion of antigen-specific effector\/memory T\u00a0cells into Foxp3-expressing Treg cells by inhibition of CDK8\/19","volume":"4","author":"Akamatsu","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fimmu.2016.00193","article-title":"Breaking free of control: how conventional T\u00a0cells overcome regulatory T\u00a0cell suppression","volume":"7","author":"Mercadante","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated T\u00a0cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib42","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","article-title":"The effector T\u00a0cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T\u00a0cells","volume":"181","author":"Schneider","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib43","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.4049\/jimmunol.1402144","article-title":"Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T\u00a0cells","volume":"193","author":"Marshall","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib44","doi-asserted-by":"crossref","first-page":"648408","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-dose IL-2 therapy in autoimmune and rheumatic diseases","volume":"12","author":"Gra\u00dfhoff","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.clim.2013.02.005","article-title":"IL-2 therapy in type 1 diabetes: \u201ctrials\u201d and tribulations","volume":"149","author":"Long","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2023.112106_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.celrep.2023.112106_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of Tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.celrep.2023.112106_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112106_bib49","doi-asserted-by":"crossref","first-page":"147474","DOI":"10.1172\/jci.insight.147474","article-title":"The effects of low-dose IL-2 on Treg adoptive cell therapy in patients with Type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2023.112106_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/db11-1213","article-title":"Central role for interleukin-2 in type 1 diabetes","volume":"61","author":"Hulme","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.celrep.2023.112106_bib51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/endrev\/bnaa028","article-title":"Progress in translational tegulatory T\u00a0cell therapies for type 1 diabetes and islet transplantation","volume":"42","author":"Marfil-Garza","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.celrep.2023.112106_bib52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2023.112106_bib60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.celrep.2023.112106_bib56","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.celrep.2023.112106_bib53","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2023.112106_bib54","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","article-title":"A framework for oligonucleotide microarray preprocessing","volume":"26","author":"Carvalho","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2023.112106_bib55","doi-asserted-by":"crossref","first-page":"100195","DOI":"10.1016\/j.xpro.2020.100195","article-title":"Assessing IL-2-induced STAT5 phosphorylation in fixed, permeabilized Foxp3+ Treg cells by multiparameter flow cytometry","volume":"1","author":"Li","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.celrep.2023.112106_bib57","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.molcel.2019.03.027","article-title":"ULK1 and ULK2 regulate stress Granule Disassembly through phosphorylation and activation of VCP\/p97","volume":"74","author":"Wang","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2023.112106_bib58","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010587","article-title":"Peaks DB: de novo sequencing assisted database search for sensitive and accurate peptide identification","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.celrep.2023.112106_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/pr025556v","article-title":"Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC\/LC-MS\/MS) for large-scale protein analysis: the yeast proteome","volume":"2","author":"Peng","year":"2003","journal-title":"J.\u00a0Proteome Res."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:59:42Z","timestamp":1761911982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2211124723001171"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112106","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T\u00a0cell development","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"112106"}}